DALLAS, Oct. 3 /PRNewswire-FirstCall/ -- Austin Medical Technologies
(OTC Pink Sheets: AMTV) will present its company to an audience of equity
investors including venture capital firms, high net worth individuals and
corporate investors looking for the best investment opportunities among a
carefully selected and very well prepared group. This year's event features a
wide range of companies from those just starting out to mature companies that
are financing new growth. Austin Medical Technologies is one of 28 companies
selected, and one of only 3 Life Science firms, selected to participate in
this prestigious event.
Keith Tarter, CEO of Austin Medical Technologies said; "We are honored to
have been selected to present to the SW Equity Capital Summit. We expect to
raise the additional capital needed to support the high growth the company is
experiencing."
About Austin Medical Technologies, Inc.:
Austin Medical Technologies delivers "DIRECT" from the manufacturer to the
Surgeon, the only technology based, "Single Source Supply Solution" for custom
sterile procedure trays (CPTs) and medical devices dedicated exclusively to
the multi-specialty Ambulatory Surgery Center (ASC) market. Under the brand
name eyeDirecti, Austin MedTech is initially focused on Ophthalmology owned
and operated ASCs which consist of 2,500 practices with 15,000 surgeons
performing 4.4 million surgical procedures represents a market size of
$400,000,000 annually. Visit our e-commerce site at http://www.eyedirecti.com
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Certain information included in this
communication (as well as information included in oral statements or other
written statements made or to be made by Austin Medical Technologies, Inc. or
its wholly owned subsidiaries) contains statements that are forward-looking,
such as statements relating to the future anticipated direction of the medical
and technology industries and plans for future expansion, various business
development activities, planned capital expenditures, future funding sources,
anticipated sales growth and potential contracts. Such forward-looking
information involves important risks and uncertainties that could
significantly affect anticipated results in the future and, accordingly, such
results may differ from those expressed in any forward-looking statements made
by or on behalf of Austin Medical Technologies or its wholly owned
subsidiaries. These risks and uncertainties include, but are not limited to,
those relating to development and expansion activities, dependence on existing
management, financial activities, domestic and global economic conditions,
changes in federal or state tax laws, and market competition factors.
SOURCE Austin Medical Technologies, Inc.
 back to top
Related links:
http://www.eyedirecti.com
CONTACT:
Keith Tarter of Austin Medical Technologies,
Inc., +1-972-370-0197, or investors@austinmedtech.com
|
